Article | February 16, 2022

Making Decentralized Clinical Trials For Rare Disease Patients Commonplace

By Caroline Potts, MRN

10 Steps To Better Alzheimer’s Disease Research

While clinical trials can be a critical key in “unlocking the gate” to the next stages of ongoing care and treatment, understanding the journey of the rare disease patient and family can provide invaluable perspectives in the development of the trial protocol, as well as its implementation. The philosophy that rare disease patients are individuals with families and lives — and not subjects — should inform every aspect of the trial.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader

MRN - Medical Research Network